# Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon

> **NCT02804386** · PHASE4 · COMPLETED · sponsor: **PharmEvo Pvt Ltd** · enrollment: 573 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** Sofosbuvir

## Key facts

- **NCT ID:** NCT02804386
- **Lead sponsor:** PharmEvo Pvt Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2017-12-31
- **Final completion:** 2018-01-30
- **Target enrollment:** 573 (ACTUAL)
- **Last updated:** 2018-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02804386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02804386, "Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02804386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*